High spatial resolution dosimetry for radioactive plaques used for radiotherapy of eye lesions

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Melanoma and squamous cell carcinoma are the commonest ocular malignancies in adults. While plaque brachytherapy has delivered advances in ocular cancer management, significant challenges remain. These include post-treatment vision loss (due to over irradiation of vital structures, e.g. optic nerve), treatment failure (~10%) and an inability to treat large tumours (>8mm thick). This project aims to address these challenges through rigorous quality assurance and enhanced dosimetry planning.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $357,294.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Autonomic nervous system

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

melanoma | ocular Inflammation | ocular disease | ocular malignancies | ocular surface disease | squamous cell carcinoma